Atlas Trials

BAY86-9766 Plus Gemcitabine Phase I Study in Asian

Clinical trial NCT01764828 · COMPLETED

Trial details

NCT number
NCT01764828
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2013-02-05
Primary completion
2014-12-18
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.